Cite
MLA Citation
Annika Nelde et al.. “HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy.” Oncoimmunology, vol. 7, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100057899097.0x000008